MedPath

Comparative effectiveness and economic evaluation of Chuna manual therapy for chronic neck pai

Not Applicable
Completed
Conditions
Diseases of the musculoskeletal system and connective tissue
Registration Number
KCT0002732
Lead Sponsor
Jaseng Medical Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
108
Inclusion Criteria

1) Chronic neck pain patients (with pain duration of 3 months or longer)
2) Patients with numeric rating scale (NRS) of radicular pain = neck pain in neck pain patients with or without radiculopathy
3) Patients with NRS of neck pain =5 during the 3 days
4) Patients who have agreed to trial participation and provided written informed consent

Exclusion Criteria

1) Patients diagnosed with serious pathology(s) which may cause neck pain (e.g. spinal metastasis of tumor(s), acute fracture, spinal dislocation)
2) Patients with neck surgery history
3) Patients with other chronic disease(s) which may interfere with treatment effect, safety, or interpretation of outcome (e.g. chronic renal failure, vertebral artery complications, rheumatoid arthritis, Down syndrome)
4) Patients with progressive neurologic deficit or severe neurologic symptoms such as spinal cord injury
5) Patients with severe mental illness
6) Patients currently taking steroids, immunosuppressants, medicine for mental illness or other medication(s) that may interfere with study results
7) Patients who have received Chuna manual therapy or physical therapy, medicine such as nonsteroidal anti-inflammatory drugs (NSAIDs), or treatment(s) that may influence pain within the past week
8) Pregnant patients or patients with plans of pregnancy
9) Patients participating in other clinical studies or otherwise deemed unsuitable by the researchers

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference between visual analogue scale (VAS) of neck pain for the past 3 days between 5 weeks post-baseline and baseline
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath